66 related articles for article (PubMed ID: 23470631)
1. Effects of lifestyle modifications on cognitive impairments in a mouse model of hypercholesterolemia.
Moreira EL; Aguiar AS; de Carvalho CR; Santos DB; de Oliveira J; de Bem AF; Xikota JC; Walz R; Farina M; Prediger RD
Neurosci Lett; 2013 Apr; 541():193-8. PubMed ID: 23470631
[TBL] [Abstract][Full Text] [Related]
2. Age-related cognitive decline in hypercholesterolemic LDL receptor knockout mice (LDLr-/-): evidence of antioxidant imbalance and increased acetylcholinesterase activity in the prefrontal cortex.
Moreira EL; de Oliveira J; Nunes JC; Santos DB; Nunes FC; Vieira DS; Ribeiro-do-Valle RM; Pamplona FA; de Bem AF; Farina M; Walz R; Prediger RD
J Alzheimers Dis; 2012; 32(2):495-511. PubMed ID: 22810096
[TBL] [Abstract][Full Text] [Related]
3. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
[TBL] [Abstract][Full Text] [Related]
4. Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress.
de Oliveira J; Hort MA; Moreira EL; Glaser V; Ribeiro-do-Valle RM; Prediger RD; Farina M; Latini A; de Bem AF
Neuroscience; 2011 Dec; 197():99-106. PubMed ID: 21945034
[TBL] [Abstract][Full Text] [Related]
5. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
[TBL] [Abstract][Full Text] [Related]
6. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.
Nomura S; Merched A; Nour E; Dieker C; Oka K; Chan L
Gene Ther; 2004 Oct; 11(20):1540-8. PubMed ID: 15269711
[TBL] [Abstract][Full Text] [Related]
8. Improvement of atherosclerosis and stiffness of the thoracic descending aorta with cholesterol-lowering therapies in familial hypercholesterolemia.
Tomochika Y; Okuda F; Tanaka N; Wasaki Y; Tokisawa I; Aoyagi S; Morikuni C; Ono S; Okada K; Matsuzaki M
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):955-62. PubMed ID: 8696959
[TBL] [Abstract][Full Text] [Related]
9. Antiatherogenic effects of cilostazol and probucol alone, and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet.
Yoshikawa T; Mitani K; Kotosai K; Nozako M; Miyakoda G; Yabuuchi Y
Horm Metab Res; 2008 Jul; 40(7):473-8. PubMed ID: 18404599
[TBL] [Abstract][Full Text] [Related]
10. Does methylmercury-induced hypercholesterolemia play a causal role in its neurotoxicity and cardiovascular disease?
Moreira EL; de Oliveira J; Dutra MF; Santos DB; Gonçalves CA; Goldfeder EM; de Bem AF; Prediger RD; Aschner M; Farina M
Toxicol Sci; 2012 Dec; 130(2):373-82. PubMed ID: 22903822
[TBL] [Abstract][Full Text] [Related]
11. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
Wang J; Huff E; Janecka L; Hegele RA
Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
[TBL] [Abstract][Full Text] [Related]
12. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor.
Benítez S; Ordóñez-Llanos J; Franco M; Marín C; Paz E; López-Miranda J; Otal C; Pérez-Jiménez F; Sánchez-Quesada JL
Am J Cardiol; 2004 Feb; 93(4):414-20. PubMed ID: 14969613
[TBL] [Abstract][Full Text] [Related]
13. [Probucol treatment of hyperlipidemia].
Koizumi J
Nihon Rinsho; 1994 Dec; 52(12):3279-84. PubMed ID: 7853723
[TBL] [Abstract][Full Text] [Related]
14. Where are we with probucol: a new life for an old drug?
Yamashita S; Matsuzawa Y
Atherosclerosis; 2009 Nov; 207(1):16-23. PubMed ID: 19457483
[TBL] [Abstract][Full Text] [Related]
15. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
16. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
Stein CS; Martins I; Davidson BL
J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
[TBL] [Abstract][Full Text] [Related]
17. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
18. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
[TBL] [Abstract][Full Text] [Related]
19. Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.
Elis A; Zhou R; Stein EA
Am J Cardiol; 2011 Jul; 108(2):223-6. PubMed ID: 21545982
[TBL] [Abstract][Full Text] [Related]
20. Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage.
Cichon G; Willnow T; Herwig S; Uckert W; Löser P; Schmidt HH; Benhidjeb T; Schlag PM; Schnieders F; Niedzielska D; Heeren J
J Gene Med; 2004 Feb; 6(2):166-75. PubMed ID: 14978770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
